News

Rice Protein Based Infant Formula Market Analysis Spreads In 108 Pages with 146 Figures and Tables – Sector : Consumer Goods

Umang January 12, 2023

1 minute read

[108 Pages Report with Detailed Analysis] Rice Protein Based Infant Formula Market (Description) : The rice protein formula is available without a prescription. It can be used as an alternative to widely hydrolyzed formulations (EHF) or soy protein formulations.

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at USD million in the year 2022, is projected to reach a revised size of USD million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

The USA market for Rice Protein Based Infant Formula is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for Rice Protein Based Infant Formula is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for Rice Protein Based Infant Formula is estimated to increase from USD million in 2022 to reach USD million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key manufacturers of Rice Protein Based Infant Formula include Bayer, Biolab, Lactalis International, Kate Farms, La Mandorle, Laboratorios Ordesa and Nucitec, etc. In 2021, the global top five players had a share approximately % in terms of revenue.

SEGMENTATION ANALYSIS

Top Key players:

Bayer
Biolab
Lactalis International
Kate Farms
La Mandorle
Laboratorios Ordesa

Nucitec

By Types

Non-GMO Infant Formula

GMO Infant Formula

By Application

0-6 Months

6-12 Months

1-3 Years

Get a Sample PDF of report – https://www.360researchreports.com/enquiry/request-sample/21938996